Logo: Four dots and StockDot set in typeface Coolvetica
An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for NEKTAR THERAPEUTICS
Ticker NKTR
FIGI BBG000BHCYJ1
CUSIP 640268108
Sector Healthcare
Equity Type Common Stock
No. Companies Holding this Equity 129 / 1.9%
Percentage held by institutional investors 71.4%

About

Nektar Therapeutics (Nektar) is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. Wikipedia